|
|
| Research article summary (published 30 Aug 2001): |
Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics.
Full Abstract
There is widespread evidence that schizophrenic symptomatology is best represented by three syndromes (positive, negative, disorganized). Both the disorganized and negative syndrome have been found to correlate with several neurocognitive dysfunctions. However, previous studies investigated samples predominantly treated with typical neuroleptics, which frequently induce parkinsonian symptoms that are hard to disentangle from primary negative symptoms and may have inflated correlations with neurocognition. A newly developed psychopathological instrument called the Positive and Negative and Disorganized Symptoms Scale (PANADSS) was evaluated in 60 schizophrenic patients. Forty-seven participants treated with atypical neuroleptics performed several neurocognitive tasks.A three-factor solution of schizophrenic symptomatology emerged. Negative symptomatology was associated with diminished creative verbal fluency and digit span backward, whereas disorganization was significantly correlated with impaired Stroop, WCST and Trail-Making Test B performance.Data suggest that disorganization is associated with tasks that demand executive functioning. Previous findings reporting correlations between negative symptomatology and neurocognition may have been confounded by the adverse consequences of typical neuroleptics.
Author information
Author/s: Moritz, S (S); Andresen, B (B); Jacobsen, D (D); Mersmann, K (K); Wilke, U (U); Lambert, M (M); Naber, D (D); Krausz, M (M);
Affiliation: Universitäts-Krankenhaus Hamburg-Eppendorf, Klinik für Psychiatrie und Psychotherapie, Martinistrasse 52, D-20246, Hamburg, Germany. moritz(-atsign-)uke.uni-hamburg.de
Journal and publication information
Publication Type: Journal Article
Journal: European psychiatry : the journal of the Association of European Psychiatrists (Eur Psychiatry), published in France. (Language: eng)
Reference: 2001-Sep; vol 16 (issue 6) : pp 354-61
Dates: Created 2001/10/04; Completed 2001/12/07; Revised 2004/11/17;
PMID: 11585716, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
30 Dec 1996 - New drugs for the treatment of schizophrenic patients.
30 Dec 1994 - [Clinical effects of clozapine: effect on negative symptoms]
29 Jun 1996 - Negative parkinsonian, depressive and catatonic symptoms in schizophrenia: a conflict of paradigms revisited.
19 Dec 1999 - P300 and symptom improvement in schizophrenia.
29 Sep 2001 - Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
30 Aug 1982 - New pharmacotherapeutic modalities for negative symptoms in psychosis.
30 Dec 1994 - Long-term treatment of mood disorders in schizophrenia.
30 Dec 1994 - Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
29 Nov 1993
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.